Problem statement: Answer the multiple-choice question.
Query: Which drug exhibits a -3.105\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a. Cc1noc(C(=O)N(C)c2ccccc2)c1Cl
b. COc1cccc(NC(=O)CN(C)C(=O)CC(NC(=O)c2ccccc2Cl)c2ccccc2)c1
Answer: b. COc1cccc(NC(=O)CN(C)C(=O)CC(NC(=O)c2ccccc2Cl)c2ccccc2)c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1cccc(NC(=O)CN(C)C(=O)CC(NC(=O)c2ccccc2Cl)c2ccccc2)c1
COc1cccc(NC(=O)CN(C)C(=O)CC(NC(=O)c2ccccc2Cl)c2ccccc2)c1
2-chloro-N-[3-[[2-(5-methoxyanilino)-2-oxoethyl]-methylamino]-3-oxo-1-phenylpropyl]benzamide